Barbanti, Piero
Goadsby, Peter J.
Lambru, Giorgio
Ettrup, Anders
Christoffersen, Cecilie Laurberg
Josiassen, Mette Krog
Phul, Ravinder
Sperling, Bjørn
Article History
Received: 15 September 2022
Accepted: 2 November 2022
First Online: 2 December 2022
Declarations
:
: The study was conducted in accordance with standards of Good Clinical Practice as defined by the International Conference on Harmonisation, as well as all applicable federal and local regulations. The local review board or central institutional review board or ethics committee approved the study at each site, and patients provided written informed consent prior to any study procedures.
: Not applicable.
: <b>Dr Barbanti</b> has received travel grants, honoraria for advisory boards, speaker panels, research support or clinical investigation studies from Alder, Allergan, Angelini, Assosalute, Bayer, Biohaven, electroCore, Eli Lilly, GSK, Lundbeck, Lusofarmaco, 1MED, MSD, New Penta, Noema Pharma, Novartis, STX-Med, Teva, Visufarma, and Zambon, and serves as President with the Italian Neurological Association for Headache Research.<b>Dr Goadsby</b> reports, over the last 36 months, grants and personal fees from Eli-Lilly and Company, a grant from Celgene, and personal fees from Aeon Biopharma, Allergan/AbbVie, Biodelivery Sciences International, CoolTech LLC, Dr. Reddys, Epalex, Impel Neuropharma, Lundbeck, Novartis, Pfizer, Praxis, Sanofi, Satsuma, and Teva Pharmaceuticals. He also reports personal fees for advice through Gerson Lehrman Group, Guidepoint, SAI Med Partners, and Vector Metric; fees for educational materials from CME Outfitters, Omnia Education, and WebMD; publishing royalties or fees from Massachusetts Medical Society, Oxford University Press, UptoDate, and Wolters Kluwer; fees for medicolegal advice in headache; and a patent for magnetic stimulation for headache (No. WO2016090333 A1) assigned to eNeura without fee.<b>Dr Lambru</b> has received speaker honoraria and funding for travel and has received honoraria for participation in advisory boards sponsored by Allergan, Eli Lilly, Lundbeck, Novartis, and Teva. He has received speaker honoraria and funding for travel from electroCore, Nevro Corp, and Autonomic Technologies.<b>Dr Ettrup, Ms Christoffersen, Dr Josiassen, Dr Phul</b> and <b>Dr Sperling</b> are current employees of H. Lundbeck A/S.